A Phase I Study of Weekly Gemcitabine and Docetaxel in Patients with Advanced Cancer: A Hoosier Oncology Group Study

A phase I study of decitabine (DCT) in combination with doxorubicin (DOX) and cyclophosphamide (CTX) in the treatment of relapsed or refractory solid tumors: A Children’s Oncology Group Study

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.8530 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 8530-8530 ◽

Cited By ~ 1

Author(s):

R. E. George ◽

C. Medeiros-Nancarrow ◽

P. C. Adamson ◽

S. M. Blaney ◽

V. Kidd ◽

...

Keyword(s):

Phase I ◽

Solid Tumors ◽

Phase I Study ◽

Oncology Group ◽

A phase I study of paclitaxel, topotecan, cisplatin and Filgrastim in patients with newly diagnosed advanced ovarian epithelial malignancies: A Gynecologic Oncology Group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2007.01.039 ◽

2007 ◽

Vol 105 (3) ◽

pp. 667-671 ◽

Cited By ~ 10

Author(s):

Deborah K. Armstrong ◽

Michael A. Bookman ◽

William McGuire ◽

Robert E. Bristow ◽

Jeanne M. Schilder

Keyword(s):

Phase I ◽

Phase I Study ◽

Gynecologic Oncology ◽

Newly Diagnosed ◽

Oncology Group ◽

A Phase I Study of 90Yttrium-Ibritumomab-Tiuxetan in Children and Adolescents with Relapsed/Refractory CD20-Positive Non–Hodgkin's Lymphoma: A Children's Oncology Group Study

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-07-1060 ◽

2007 ◽

Vol 13 (18) ◽

pp. 5652s-5660s ◽

Cited By ~ 22

Author(s):

Erin Cooney-Qualter ◽

Mark Krailo ◽

Anne Angiolillo ◽

Rashid A. Fawwaz ◽

Gregory Wiseman ◽

...

Keyword(s):

Phase I ◽

Children And Adolescents ◽

Phase I Study ◽

Hodgkin’S Lymphoma ◽

Hodgkin's Lymphoma ◽

Oncology Group ◽

Ibritumomab Tiuxetan ◽

Oncology Group Study ◽

Non Hodgkin’S Lymphoma ◽

Non Hodgkin's Lymphoma

Phase I Study of Recombinant Human Interleukin-2 for Pediatric Malignancies: Feasibility of Outpatient Therapy. A Pediatric Oncology Group Study

Journal of Immunotherapy ◽

10.1097/00002371-199208000-00009 ◽

1992 ◽

Vol 12 (2) ◽

pp. 138-146 ◽

Cited By ~ 7

Author(s):

Ray C. Pais ◽

Aly Abdel-Mageed ◽

Thad T. Ghim ◽

David Ode ◽

Eliazer Melendez ◽

...

Keyword(s):

Phase I ◽

Pediatric Oncology ◽

Phase I Study ◽

Interleukin 2 ◽

Oncology Group ◽

Outpatient Therapy ◽

Oncology Group Study ◽

Pediatric Malignancies ◽

Pediatric Oncology Group

Phase I study of paclitaxel with standard dose ifosfamide in children with refractory solid tumors: A Pediatric Oncology Group study (POG 9376)

Pediatric Blood & Cancer ◽

10.1002/pbc.21820 ◽

2009 ◽

Vol 52 (3) ◽

pp. 346-350 ◽

Cited By ~ 10

Author(s):

James I. Geller ◽

Donna Wall ◽

John Perentesis ◽

Susan M. Blaney ◽

Mark Bernstein

Keyword(s):

Phase I ◽

Solid Tumors ◽

Pediatric Oncology ◽

Phase I Study ◽

Standard Dose ◽

Oncology Group ◽

Oncology Group Study ◽

Pediatric Oncology Group

A phase I study of continuous veliparib in combination with IV carboplatin/paclitaxel or IV/IP paclitaxel/cisplatin and bevacizumab in newly diagnosed patients with previously untreated epithelial ovarian, fallopian tube, or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study.

Journal of Clinical Oncology ◽

10.1200/jco.2015.33.15_suppl.5507 ◽

2015 ◽

Vol 33 (15_suppl) ◽

pp. 5507-5507 ◽

Cited By ~ 15

Author(s):

Katherine M. Bell-McGuinn ◽

William E Brady ◽

Russell J. Schilder ◽

Paula M Fracasso ◽

Kathleen N. Moore ◽

...

Keyword(s):

Phase I ◽

Fallopian Tube ◽

Phase I Study ◽

Gynecologic Oncology ◽

Newly Diagnosed ◽

Oncology Group ◽

Oncology Group Study ◽

Primary Peritoneal Cancer ◽

Peritoneal Cancer

A phase I study with an expanded cohort to assess the feasibility of intraperitoneal carboplatin and intravenous paclitaxel in untreated ovarian, fallopian tube, and primary peritoneal carcinoma: A Gynecologic Oncology Group study

Gynecologic Oncology ◽

10.1016/j.ygyno.2010.12.358 ◽

2011 ◽

Vol 121 (2) ◽

pp. 264-268 ◽

Cited By ~ 16

Author(s):

Mark A. Morgan ◽

Michael W. Sill ◽

Keiichi Fujiwara ◽

Benjamin Greer ◽

Stephen C. Rubin ◽

...

Keyword(s):

Phase I ◽

Fallopian Tube ◽

Phase I Study ◽

Gynecologic Oncology ◽

Oncology Group ◽

Peritoneal Carcinoma ◽

Oncology Group Study ◽

Primary Peritoneal Carcinoma

Phase I study of a 120-hour continuous intravenous infusion of 5-fluorouracil in pediatric patients with recurrent solid tumors: A pediatric oncology group study

Medical and Pediatric Oncology ◽

10.1002/mpo.2950180413 ◽

1990 ◽

Vol 18 (4) ◽

pp. 321-324 ◽

Cited By ~ 6

Author(s):

Daniel M. Green ◽

Jeffrey P. Krischer ◽

Beverly Bell ◽

Martin L. Brecher ◽

Barbara Cushing ◽

...

Keyword(s):

Phase I ◽

Solid Tumors ◽

Pediatric Oncology ◽

Intravenous Infusion ◽

Phase I Study ◽

Pediatric Patients ◽

Continuous Intravenous Infusion ◽

Oncology Group ◽

Oncology Group Study ◽

Pediatric Oncology Group

Phase I study of combination chemotherapy with irinotecan hydrochloride and nedaplatin for cervical squamous cell carcinoma: Japanese gynecologic oncology group study

Oncology Reports ◽

10.3892/or_00000316 ◽

2009 ◽

Vol 21 (4) ◽

Cited By ~ 22

Author(s):

Yamamoto

Keyword(s):

Squamous Cell Carcinoma ◽

Phase I ◽

Combination Chemotherapy ◽

Phase I Study ◽

Gynecologic Oncology ◽

Cervical Squamous Cell Carcinoma ◽

Oncology Group ◽

Oncology Group Study ◽

Irinotecan Hydrochloride

Phase I study of decitabine with doxorubicin and cyclophosphamide in children with neuroblastoma and other solid tumors: A children's oncology group study

Pediatric Blood & Cancer ◽

10.1002/pbc.22607 ◽

2010 ◽

Vol 55 (4) ◽

pp. 629-638 ◽

Cited By ~ 32

Author(s):

Rani E. George ◽

Jill M. Lahti ◽

Peter C. Adamson ◽

Kejin Zhu ◽

David Finkelstein ◽

...

Keyword(s):

Phase I ◽

Solid Tumors ◽

Phase I Study ◽

Oncology Group ◽